The effectiveness of the new Russian meds coronavirus “Avidavit” is more than 80 percent. About this newspaper “Izvestia” with reference to the Russian direct investment Fund (RDIF).
It is noted that clinical studies of this drug will last until the end of the summer. “Already produced 18 thousand packages of the drug in June the plan is to put in a Russian hospital over 60 thousand packages. Technological capacity can produce 60 thousand packages a month, 720 thousand units per year”, — told in the Fund.
It is proved that the drug allows to reduce the period of treatment of the disease to four days instead of nine while taking standard medications. At this stage test COVID-19 showed a negative result in 65 percent of patients, and on the tenth day of treatment — 90 percent.
Earlier it was reported that “Aviewer” a joint production of RDIF and Chemrar has received approval from the Ministry of health of Russia. According to the CEO of RDIF, Kirill Dmitriev, “Avidavit” is currently the most promising drug from the fashion industry not only in Russia but also in the world.
Video, photo All from Russia.